The prevention of bone fractures after liver transplantation: Experience with alendronate treatment
Makaleler > Tam Makale · 2006
Yazarlar: Funda ÇALIŞ, Asiye Simin HEPGÜLER, Abdullah Zeki KARASU, Murat KILIÇ, Y TOKAT
TRANSPLANTATION PROCEEDINGS, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2006, cilt 38, ss 1448-1452
DOI: 10.1016/j.transproceed.2006.02.074
Özet
Objective. The aim of this study was to prevent fractures in the first postoperative year. Methods and patients. We studied 59 patients (48 men, 11 women) aged 42.6 +/- 11.4 years, who underwent liver transplantation. All patients received oral alendronate 70 mg weekly and calcium 1 g and calcitriol 0.5 mu g daily. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry at the lumbar spine and proximal femur at baseline as well as at 6 and 12 months after transplantation for comparison with an historical control group (n = 31). Spinal radiographs were obtained to assess vertebral fractures at the same time. Additionally, serum osteocalcin, serum parathyroid hormone (PTH), urinary deoxypyridinoline (DPD), and biochemical parameters were determined every 3 months.